September 22, 2016
Teva, Apotex, Mylan and Glenmark unlawfully conspired to artificially inflate prices for generic versions of cholesterol drug pravastatin by more than 500 percent, according to a union's proposed class action filed Wednesday in Pennsylvania federal court.